These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22904346)

  • 1. Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity.
    Shi X; Yao D; Gosnell BA; Chen C
    J Lipid Res; 2012 Nov; 53(11):2318-30. PubMed ID: 22904346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.
    Chen C; Krausz KW; Shah YM; Idle JR; Gonzalez FJ
    Chem Res Toxicol; 2009 Apr; 22(4):699-707. PubMed ID: 19256530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.
    Huang J; Das SK; Jha P; Al Zoughbi W; Schauer S; Claudel T; Sexl V; Vesely P; Birner-Gruenberger R; Kratky D; Trauner M; Hoefler G
    Biochim Biophys Acta; 2013 Oct; 1831(10):1555-65. PubMed ID: 23628473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity.
    Patterson AD; Shah YM; Matsubara T; Krausz KW; Gonzalez FJ
    Hepatology; 2012 Jul; 56(1):281-90. PubMed ID: 22318764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice.
    Dong Y; Lu H; Li Q; Qi X; Li Y; Zhang Z; Chen J; Ren J
    Life Sci; 2019 Sep; 232():116644. PubMed ID: 31301418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism disorders contribute to hepatotoxicity of triclosan in mice.
    Huang W; Xie P; Cai Z
    J Hazard Mater; 2020 Feb; 384():121310. PubMed ID: 31586915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
    Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process.
    Lee JN; Dutta RK; Kim SG; Lim JY; Kim SJ; Choe SK; Yoo KW; Song SR; Park DS; So HS; Park R
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):22-7. PubMed ID: 24211584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway.
    Zhang Y; Guo H; Hassan HM; Ding PP; Su Y; Song Y; Wang T; Sun L; Zhang L; Jiang Z
    J Appl Toxicol; 2016 Dec; 36(12):1579-1590. PubMed ID: 27071702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice.
    Bjørndal B; Alterås EK; Lindquist C; Svardal A; Skorve J; Berge RK
    Nutr Metab (Lond); 2018; 15():10. PubMed ID: 29422939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
    Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
    Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M; Bu L; Ma Y; Liu D
    PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.